156 related articles for article (PubMed ID: 33126171)
1. Evaluation of contrast-enhanced computed tomography for the differential diagnosis of hypovascular pancreatic neuroendocrine tumors from chronic mass-forming pancreatitis.
Ren S; Qian L; Daniels MJ; Duan S; Chen R; Wang Z
Eur J Radiol; 2020 Dec; 133():109360. PubMed ID: 33126171
[TBL] [Abstract][Full Text] [Related]
2. Differentiation between non-hypervascular pancreatic neuroendocrine tumors and mass-forming pancreatitis using contrast-enhanced computed tomography.
Wang Y; Chen X; Wang J; Cui W; Wang C; Chen X; Wang Z
Acta Radiol; 2021 Feb; 62(2):190-197. PubMed ID: 32375515
[TBL] [Abstract][Full Text] [Related]
3. Differentiation of hypovascular pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Wang Z; Zhao R; Wang J; Cui W; Wang Z
PLoS One; 2019; 14(2):e0211566. PubMed ID: 30707733
[TBL] [Abstract][Full Text] [Related]
4. Pancreatic neuroendocrine tumors containing areas of iso- or hypoattenuation in dynamic contrast-enhanced computed tomography: Spectrum of imaging findings and pathological grading.
Hyodo R; Suzuki K; Ogawa H; Komada T; Naganawa S
Eur J Radiol; 2015 Nov; 84(11):2103-9. PubMed ID: 26321494
[TBL] [Abstract][Full Text] [Related]
5. Nonhypervascular pancreatic neuroendocrine tumors: Spectrum of MDCT imaging findings and differentiation from pancreatic ductal adenocarcinoma.
Karmazanovsky G; Belousova E; Schima W; Glotov A; Kalinin D; Kriger A
Eur J Radiol; 2019 Jan; 110():66-73. PubMed ID: 30599875
[TBL] [Abstract][Full Text] [Related]
6. Differentiation of chronic mass-forming pancreatitis from pancreatic ductal adenocarcinoma using contrast-enhanced computed tomography.
Ren S; Chen X; Cui W; Chen R; Guo K; Zhang H; Chen S; Wang Z
Cancer Manag Res; 2019; 11():7857-7866. PubMed ID: 31686905
[TBL] [Abstract][Full Text] [Related]
7. Quantitative analysis of enhanced CT in differentiating well-differentiated pancreatic neuroendocrine tumors and poorly differentiated neuroendocrine carcinomas.
Chen HY; Pan Y; Chen JY; Liu LL; Yang YB; Li K; Yu RS; Shao GL
Eur Radiol; 2022 Dec; 32(12):8317-8325. PubMed ID: 35759016
[TBL] [Abstract][Full Text] [Related]
8. Comparison between neuroendocrine carcinomas and well-differentiated neuroendocrine tumors of the pancreas using dynamic enhanced CT.
Park HJ; Kim HJ; Kim KW; Kim SY; Choi SH; You MW; Hwang HS; Hong SM
Eur Radiol; 2020 Sep; 30(9):4772-4782. PubMed ID: 32346794
[TBL] [Abstract][Full Text] [Related]
9. Differentiation of intrapancreatic accessory spleen from small hypervascular neuroendocrine tumor of the pancreas: textural analysis on contrast-enhanced computed tomography.
Lin X; Xu L; Wu A; Guo C; Chen X; Wang Z
Acta Radiol; 2019 May; 60(5):553-560. PubMed ID: 30086651
[TBL] [Abstract][Full Text] [Related]
10. Differentiation of pancreatic neuroendocrine tumors from pancreas renal cell carcinoma metastases on CT using qualitative and quantitative features.
van der Pol CB; Lee S; Tsai S; Larocque N; Alayed A; Williams P; Schieda N
Abdom Radiol (NY); 2019 Mar; 44(3):992-999. PubMed ID: 30603880
[TBL] [Abstract][Full Text] [Related]
11. Prediction of lymph node metastasis in pancreatic neuroendocrine tumors by contrast enhancement characteristics.
Mizumoto T; Toyama H; Terai S; Mukubou H; Yamashita H; Shirakawa S; Nanno Y; Sofue K; Kido M; Ajiki T; Fukumoto T
Pancreatology; 2017; 17(6):956-961. PubMed ID: 28964660
[TBL] [Abstract][Full Text] [Related]
12. Nonhypervascular Pancreatic Neuroendocrine Tumors: Differential Diagnosis from Pancreatic Ductal Adenocarcinomas at MR Imaging-Retrospective Cross-sectional Study.
Jeon SK; Lee JM; Joo I; Lee ES; Park HJ; Jang JY; Ryu JK; Lee KB; Han JK
Radiology; 2017 Jul; 284(1):77-87. PubMed ID: 28092495
[TBL] [Abstract][Full Text] [Related]
13. Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.
Li J; Lu J; Liang P; Li A; Hu Y; Shen Y; Hu D; Li Z
Cancer Med; 2018 Oct; 7(10):4924-4931. PubMed ID: 30151864
[TBL] [Abstract][Full Text] [Related]
14. Application of low dose pancreas perfusion CT combined with enhancement scanning in diagnosis of pancreatic neuroendocrine tumors.
Wan Y; Hao H; Meng S; Li Z; Yu F; Meng Chi ; Chao Q; Gao J
Pancreatology; 2021 Jan; 21(1):240-245. PubMed ID: 33191144
[TBL] [Abstract][Full Text] [Related]
15. Textural analysis on contrast-enhanced CT in pancreatic neuroendocrine neoplasms: association with WHO grade.
Guo C; Zhuge X; Wang Z; Wang Q; Sun K; Feng Z; Chen X
Abdom Radiol (NY); 2019 Feb; 44(2):576-585. PubMed ID: 30182253
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic ductal adenocarcinoma and chronic mass-forming pancreatitis: Differentiation with dual-energy MDCT in spectral imaging mode.
Yin Q; Zou X; Zai X; Wu Z; Wu Q; Jiang X; Chen H; Miao F
Eur J Radiol; 2015 Dec; 84(12):2470-6. PubMed ID: 26481480
[TBL] [Abstract][Full Text] [Related]
17. Differential diagnosis between pancreatic solid pseudopapillary tumors and pancreatic neuroendocrine tumors based on contrast enhanced ultrasound imaging features.
Zhang Q; Qiu YJ; Yang DH; Lu XY; Chen S; Dong Y; Wang WP
Clin Hemorheol Microcirc; 2023; 85(4):421-431. PubMed ID: 37718786
[TBL] [Abstract][Full Text] [Related]
18. MRI-based radiomics approach for differentiation of hypovascular non-functional pancreatic neuroendocrine tumors and solid pseudopapillary neoplasms of the pancreas.
Song T; Zhang QW; Duan SF; Bian Y; Hao Q; Xing PY; Wang TG; Chen LG; Ma C; Lu JP
BMC Med Imaging; 2021 Feb; 21(1):36. PubMed ID: 33622277
[TBL] [Abstract][Full Text] [Related]
19. Prediction of Pancreatic Neuroendocrine Tumor Grade Based on CT Features and Texture Analysis.
Canellas R; Burk KS; Parakh A; Sahani DV
AJR Am J Roentgenol; 2018 Feb; 210(2):341-346. PubMed ID: 29140113
[TBL] [Abstract][Full Text] [Related]
20. Pancreatic neuroendocrine tumors (pNETs): the predictive value of MDCT characteristics in the differentiation of histopathological grades.
Salahshour F; Mehrabinejad MM; Zare Dehnavi A; Alibakhshi A; Dashti H; Ataee MA; Ayoobi Yazdi N
Abdom Radiol (NY); 2020 Oct; 45(10):3155-3162. PubMed ID: 31897681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
